A joint project of MHH and TK Niedersachsen is being implemented nationwide.

The ATMP-GMPDU development unit at the Institute for Cell Therapeutics supports research groups in the development of new cellular drugs.

A clinical trial under MHH leadership is testing a new therapy with immune cells against the JC virus.

Chronic fatigue syndrome (CFS) is a heavy burden. The "EXTINCT post COVID" project is investigating the effectiveness of apheresis therapy and is…

What framework conditions do children and young people need for good psychosocial development? This is what the MHH and the University of Hildesheim…

Budget and Finance Committee of the Lower Saxony State Parliament made a milestone decision.

The telemedical project is intended to support General Practitioners (GPs) in the care of people with post-COVID syndrome.

In a multicentre phase 3 trial, researchers at the MHH have demonstrated the efficacy and safety of the drug Bulevirtide, which prevents HD viruses…

The MHH plus foundation honours Professor Dr. Hinrich Abken and Dr. Mark Schmitt.

The MHH is participating in the EU project PIECES and aims to reduce the risk of cancer and improve liver health with personalized exercise programs.